← back to search

Manja Lehmann

University of Pecs · HU
Area of research
Psychiatry and Mental health · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Advanced Neuroimaging Techniques and Applications.
h-index
36
citations
7,327
works
140
NIH funding
primary concept
email

Recent publications

Non‐memory cognitive symptom development in Alzheimer's disease
European Journal of Neurology 2020cited by 9position: middledoi
Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy
Brain 2019cited by 84position: middledoi
CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
Annals of Clinical and Translational Neurology 2018cited by 35position: middledoi
Consensus classification of posterior cortical atrophy
Alzheimer s & Dementia 2017cited by 651position: middledoi
Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease
Alzheimer s & Dementia 2016cited by 129position: middledoi
Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort
NeuroImage Clinical 2016cited by 64position: middledoi
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Brain 2015cited by 430position: middledoi
Atrophy patterns in early clinical stages across distinct phenotypes of <scp>A</scp>lzheimer's disease
Human Brain Mapping 2015cited by 257position: middledoi
Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants
Neurobiology of Aging 2015cited by 82position: firstdoi
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
NeuroImage Clinical 2014cited by 76position: middledoi
Motor features in posterior cortical atrophy and their imaging correlates
Neurobiology of Aging 2014cited by 33position: middledoi
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease
Brain 2013cited by 332position: firstdoi
Progranulin Mutations as Risk Factors for Alzheimer Disease
JAMA Neurology 2013cited by 133position: middledoi
Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s disease
Proceedings of the National Academy of Sciences 2013cited by 124position: firstdoi
Shining a light on posterior cortical atrophy
Alzheimer s & Dementia 2012cited by 90position: middledoi
Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers
Neurobiology of Aging 2012cited by 45position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Gil D. Rabinovici · Harvard University9 papers (2012–2016)Bruce L. Miller · University at Buffalo, State University of New York8 papers (2013–2016)William J. Jagust · Berkeley College7 papers (2013–2016)William W. Seeley · Hammersmith Hospital7 papers (2013–2016)Howard J. Rosen · Medical University of South Carolina5 papers (2013–2016)Pia Ghosh · Karolinska University Hospital5 papers (2013–2015)Cindee Madison · University of California San Francisco Medical Center5 papers (2013–2015)Maria Luisa Gorno‐Tempini · University Memory and Aging Center4 papers (2013–2015)Nick C. Fox · Hospital Universitario Ramón y Cajal4 papers (2012–2018)Wiesje M. van der Flier · Alzheimer Nederland3 papers (2012–2020)Jonathan M. Schott · Sungkyunkwan University3 papers (2012–2018)Michael D. Greicius · Stanford Medicine3 papers (2013–2015)Lea T. Grinberg · Mayo Clinic in Arizona3 papers (2013–2016)Joel H. Kramer · Cisco Systems (United States)3 papers (2013–2015)Philip Scheltens · University Hospital Cologne3 papers (2012–2015)Sebastian J. Crutch · UK Dementia Research Institute2 papers (2012–2014)Timothy J. Shakespeare · UK Dementia Research Institute2 papers (2012–2014)Nagehan Ayakta · Stanford University2 papers (2015–2016)Giovanni Coppola · Regeneron (United States)2 papers (2013–2015)Frederik Barkhof · The Queen's Medical Research Institute2 papers (2012–2015)